Changes in collagenases and TGF-β precede structural alterations in a model of chronic renal fibrosis

被引:27
|
作者
Mo, W
Brecklin, C
Garber, SL
Song, RH
Pegoraro, AA
Au, J
Arruda, JAL
Dunea, G
Singh, AK
机构
[1] Hektoen Inst Med Res, Chicago, IL 60612 USA
[2] Univ Illinois, Cook Cty Hosp, Div Nephrol, Chicago, IL 60612 USA
[3] Univ Illinois, Nephrol Sect, Chicago, IL 60612 USA
[4] WSVAMC, Chicago, IL USA
[5] Univ Chicago, Dept Vasc Surg, Chicago, IL 60637 USA
关键词
transforming growth factor beta; bromoethylamine; interstitial fibrosis; collagenases; gelatinses; TIMP; papillary necrosis;
D O I
10.1046/j.1523-1755.1999.00545.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. To study the role of collagenases and transforming growth factor-beta (TGF-beta) in the genesis of interstitial fibrosis. we used the model of bromoethylamine (BEA)-induced papillary necrosis, which is known to lead over a period of 1 to 12 months to interstitial fibrosis and renal insufficiency. Methods. Rats were injected with BEA, and urine and kidney tissue (cortex and medulla) were collected after 1, 2, 3, 7, and 30 days. One kidney was perfused and fixed for morphological studies and immunostained for collagen type I. III, and IV. The other kidney was used to prepare cortex and medulla extracts for gelatinases (by fluorometric and zymographic techniques). tissue inhibitors of metalloproteinase-1 (TIMP-1), and TIMP-2 (by enzyme-linked immunosorbent assay, ELISA) and TGF-beta 1 (by ELISA). Results. Albuminuria and interstitial fibrosis were present in BEA rats by; day 7, which continued until day 30. Immunocytochemical staining for collagen types showed that collagen III and IV increased in the interstitium by day 30, but collagen I remained unchanged. Gelatinase activity in the medulla decreased bq 57% compared with control by day 2 and remained low until day 30. In the cortex, gelatinase activity remained unchanged between 0 and 7 days after BEA but decreased by 72% by day. 30. TIMP-1 and TIMP-2 were decreased by 80% compared with day 0 in both the medulla (by day 1) and cortex (bq. day 2) and remained low up to day 30. TGF-beta 1 immunoreactivity increased progressively until day 2 in the medulla (16-fold higher than control) and day 3 in the cortex (S-fold higher than control) and returned to control level by day 3 in the medulla and by day 30 in the cortex. Two days after BEA injection. the mRNA for TGF-beta 1 was increased eightfold in the cortex and 12-fold in the medulla, and it remained high for up to 30 days. Conclusions, The fibrosis that follows papillary necrosis is associated with both high TGF-beta 1 expression and depressed gelatinolytic activity.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 50 条
  • [31] Huangqi-Danshen Decoction Against Renal Fibrosis in UUO Mice via TGF-β1 Induced Downstream Signaling Pathway
    Huang, Xi
    Peng, Yu
    Lu, Lingfei
    Gao, Liwen
    Wu, Shanshan
    Lu, Jiandong
    Liu, Xinhui
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 4119 - 4134
  • [32] Alantolactone alleviates epithelial-mesenchymal transition by regulating the TGF-(3/STAT3 signaling pathway in renal fibrosis
    Hwang, Yeo Jin
    Jung, Gwon-Soo
    Lee, Kyeong-Min
    HELIYON, 2024, 10 (16)
  • [33] Chrysin Ameliorates Cyclosporine-A-Induced Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial-Mesenchymal Transition
    Nagavally, Rohan Reddy
    Sunilkumar, Siddharth
    Akhtar, Mumtaz
    Trombetta, Louis D.
    Ford, Sue M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [34] Betulinic acid attenuates renal fibrosis in rat chronic kidney disease model
    Sharma, Anshuk
    Thakur, Richa
    Lingaraju, Madhu C.
    Kumar, Dhirendra
    Mathesh, Karikalan
    Telang, Avinash G.
    Singh, Thakur Uttam
    Kumar, Dinesh
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 : 796 - 804
  • [35] TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
    Munoz-Felix, Jose M.
    Gonzalez-Nunez, Maria
    Martinez-Salgado, Carlos
    Lopez-Novoa, Jose M.
    PHARMACOLOGY & THERAPEUTICS, 2015, 156 : 44 - 58
  • [36] NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway
    Jin, Zhibo
    Gu, Chaohui
    Tian, Fengyan
    Jia, Zhankui
    Yang, Jinjian
    CELL AND TISSUE RESEARCH, 2017, 369 (03) : 603 - 610
  • [37] Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules
    Tang, Jiali
    Liu, Fang
    Cooper, Mark E.
    Chai, Zhonglin
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (08) : 721 - 738
  • [38] RETRACTED: GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF-β-Induced Smad3 Phosphorylation
    Ai, Jun
    Nie, Jing
    He, Jiangbo
    Guo, Qin
    Li, Mei
    Lei, Ying
    Liu, Youhua
    Zhou, Zhanmei
    Zhu, Fengxin
    Liang, Min
    Cheng, Yongxian
    Hou, Fan Fan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (08): : 1827 - 1838
  • [39] Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway
    Sutariya, Brijesh
    Saraf, Madhusudan
    JOURNAL OF ETHNOPHARMACOLOGY, 2017, 198 : 432 - 443
  • [40] Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction
    Zou, Junju
    Zhou, Xiaotao
    Chen, Xian
    Ma, Yuerong
    Yu, Rong
    FRONTIERS IN PHARMACOLOGY, 2022, 13